Concepedia

Thomas J. Hayman

TJ

16

Publications

739

Citations

13

H-Index

2002

Active since

Affiliations

University of South Florida(Current)

National Cancer Institute

The University of Melbourne

Yale University

Walter and Eliza Hall Institute of Medical Research

Thomas J. Hayman is an author at University of South Florida specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

2002–2023

16

Publications

16

STING enhances cell death through regulation of reactive oxygen species and DNA damage

Thomas J. Hayman, Marta Baro, Tyler MacNeil et al. · Nature Communications · 2021 · 196 citations · Full text

RIPLET, and not TRIM25, is required for endogenous RIG‐I‐dependent antiviral responses

Thomas J. Hayman, Alan Hsu, Tatiana B. Kolesnik et al. · Immunology and Cell Biology · 2019 · 98 citations

, , +15

The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells

Jenna Kahn, Thomas J. Hayman, Muhammad Jamal et al. · Neuro-Oncology · 2013 · 96 citations · Full text

CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma

William S. Chen, Ranjit S. Bindra, Allen Mo et al. · Frontiers in Oncology · 2018 · 55 citations · Full text

The ATP-Competitive mTOR Inhibitor INK128 Enhances <i>In Vitro</i> and <i>In Vivo</i> Radiosensitivity of Pancreatic Carcinoma Cells

Thomas J. Hayman, Amy Wahba, Barbara H. Rath et al. · Clinical Cancer Research · 2013 · 49 citations · Full text

Rows per page

1–5 of 16